5/15/2019 | HY | Moody’s cuts Novolex
|
5/15/2019 | HY | Moody’s cuts Novolex
|
5/15/2019 | DD | S&P lowers Evergreen Skills
|
5/15/2019 | BK | Fitch cuts Lucid Energy, rates loan BB-
|
5/15/2019 | BK | Fitch cuts Lucid Energy, rates loan BB-
|
5/15/2019 | BKDDHY | Moody’s lifts BioScrip, rates loan B2
|
5/15/2019 | BKHY | S&P rates BioScrip loan B-
|
3/18/2019 | BKDDHY | Moody’s might lift BioScrip
|
3/15/2019 | BK | BioScrip, Option Care plan $1.08 billion loans with merger
|
8/10/2018 | BKDDHY | S&P upgrades BioScrip
|
8/7/2018 | BWDDHY | BioScrip ‘confident’ it will record $75 million of EBITDA for 2018
|
7/30/2018 | BKDDHY | Moody’s upgrades BioScrip
|
8/1/2017 | BKDDHY | Moody’s ups BioScrip PDR, rates notes
|
7/5/2017 | BKDDHY | S&P rates BioScrip notes CCC+, CC
|
6/29/2017 | HYIG | Market Commentary: Bioscrip plans $310 billion facilities; Jones Lang wraps €350 million
|
6/29/2017 | PV | BioScrip negotiates $310 million new facilities to raise $300 million
|
6/29/2017 | BK | BioScrip to fully repay credit agreement debts with new note proceeds
|
1/23/2017 | DD | Market Commentary: Bleeding goes on for Neiman Marcus as it sees steep declines; Avaya up; healthcare, pharma mixed
|
1/23/2017 | HY | Market Commentary: Bleeding goes on for Neiman Marcus, declines steep; Avaya up; healthcare, pharma mixed
|
1/12/2017 | DD | Market Commentary: Valeant ‘top dog’ on most active list; Community Health swings down; Murray active; Avaya dips
|
1/10/2017 | BKDDHY | S&P assigns CCC+ to BioScrip facility
|
1/9/2017 | BK | BioScrip details amended credit agreement, new $25 million facility
|
1/6/2017 | BK | BioScrip amends credit agreement, adds $25 million senior loan facility
|
12/16/2016 | BKDDHY | S&P could lower BioScrip
|
12/14/2016 | BKDD | BioScrip aims to restructure revolver due 2018, needs $15 million cash
|
11/10/2016 | BKDDHY | S&P downgrades BioScrip
|
9/19/2016 | BKCVDDEMHY | S&P global speculative-grade default rate increases to 3.88% in July
|
8/15/2016 | BKDDHY | S&P: BioScrip view now stable
|
6/22/2016 | PP | BioScrip greenshoe exercised for $90.4 million public sale of stock
|
6/17/2016 | PP | BioScrip prices $80 million public offering of common stock at $2.00
|
6/14/2016 | PP | BioScrip arranges exchange agreement for convertible preferred stock
|
6/13/2016 | PP | BioScrip plans public sale of 40 million shares to fund acquisition
|
3/3/2016 | BKDDHY | Moody’s cuts BioScrip, loans, notes
|
8/11/2015 | BKDDHY | S&P cuts BioScrip, loan, notes
|
8/10/2015 | BK | BioScrip amends first-lien net leverage ratio under credit agreement
|
7/28/2015 | PP | BioScrip settles its $1.08 million rights offering of preferred units
|
6/30/2015 | PP | BioScrip prices $20 million rights sale of preferred units at $100.00
|
6/4/2015 | BKDDHY | S&P lowers BioScrip view to negative
|
3/9/2015 | PP | BioScrip raises $62.5 million in convertible preferreds private sale
|
3/5/2015 | BKDDHY | Moody’s drops BioScrip, loans
|
8/7/2014 | BKBWHY | BioScrip reports increased cash, debt of $419 million at end of Q2
|
5/30/2014 | BKDDHY | S&P downgrades BioScrip
|
2/10/2014 | HY | Market Commentary: B Communications, Meritor deals price, trade up; overall market seen firm, Caesars paper busy
|
2/7/2014 | BKDD | S&P ups BioScrip loans, rates notes CCC+
|
2/7/2014 | HY | Market Commentary: Lansing Trade five-year deal caps $6.6 billion primary week; most recent deals firm smartly
|
2/6/2014 | HY | New Issue: BioScrip sells $200 million seven-year notes at par to yield 8 7/8%
|
2/6/2014 | HY | Market Commentary: Oshkosh, BioScrip price; new Micron, American Greetings bonds firm; funds plunge $972 million
|
2/6/2014 | HY | BioScrip talks $200 million seven-year notes to yield 8 7/8%-9%; books close 1 p.m. ET Thursday
|
2/5/2014 | BKDD | Moody's ups BioScrip loans, rates notes Caa2
|
2/3/2014 | BK | BioScrip to pay down portion of bank debt, amends credit facilities
|
2/3/2014 | HY | BioScrip starts roadshow for $200 million seven-year notes; pricing late this week
|
2/3/2014 | HY | Market Commentary: BioScrip slates, but no pricings as stocks, weather chill primary; market anticipates Chrysler
|
12/20/2013 | BK | Moody's lowers BioScrip loans
|
7/19/2013 | HYLM | BioScrip intends to redeem all $225 million of its 101/4% senior notes
|
7/18/2013 | BK | BioScrip cuts spread on $400 million term loans to Libor plus 525 bps
|
7/18/2013 | BK | Market Commentary: Lions Gate, Guggenheim, Oxbow Carbon free up; Gardner Denver, BioScrips changes surface
|
7/11/2013 | BK | BioScrip ups spread on $400 million term loans to Libor plus 550 bps
|
7/11/2013 | BK | Market Commentary: Triple Point Group Holdings breaks; BioScrip revises deal; primary sees multiple deals launch
|
7/9/2013 | HYLM | BioScrip further extends expiration of tender offer for 101/4% notes
|
6/19/2013 | BKHY | Moody's gives BioScrip loan B2
|
6/17/2013 | BK | BioScrip to launch $475 million credit facility on Wednesday
|
6/17/2013 | BK | Market Commentary: Granite breaks; Orchard Supply gains with bankruptcy filing; BioScrip adjusts deal plans
|
6/17/2013 | HYLM | BioScrip gets tenders for 47.72% of 101/4% notes due 2015 so far
|
6/6/2013 | BK | Market Commentary: Oxea starts trading; Allflex, ValleyCrest, WildHorse Resources, BioScrip update deals
|
6/6/2013 | BK | BioScrip firms $250 million term loan B at Libor plus 375 bps
|
5/31/2013 | BKHY | S&P rates BioScrip facilities B
|
5/28/2013 | BKHY | Moody's upgrades BioScrip, assigns B2 ratings to loans
|
5/23/2013 | BK | BioScrip launches $250 million term loan at Libor plus 350-375 bps
|
5/23/2013 | BK | Market Commentary: Univision, CSM, Kindred, Blue Coat, Avis, Orbitz, Brickman, Ozburn, Mediacom, Smart break
|
5/17/2013 | BK | Market Commentary: Digital Cinema, Teine, KIK Custom Products, HCA break; Atlantic Broadband finalizes coupon
|
5/17/2013 | BK | BioScrip readies Thursday launch for $325 million credit facility
|
4/16/2013 | BK | BioScrip to get new credit facility, including $325 million term loan
|
4/16/2013 | HYLM | BioScrip intends to redeem its outstanding 101/4% senior notes
|
8/2/2012 | BK | BioScrip amends loan, trimming revolver size and Libor floor
|
2/3/2012 | BKHY | S&P affirms BioScrip at B
|
2/2/2012 | BKHY | Moody's: BioScrip unchanged
|
5/4/2011 | BKHY | S&P revises BioScrip to stable
|
4/8/2011 | BKDDHY | Moody's cuts BioScrip
|
3/15/2011 | BKHY | S&P takes BioScrip off watch
|
12/31/2010 | BK | BioScrip gets $150 million amended and restated credit facility
|
11/19/2010 | BKHY | S&P: BioScrip on CreditWatch
|
6/7/2010 | BKBWHY | BioScrip plans to reduce leverage ratio to 2-to-1 within three years
|
3/25/2010 | BK | Market Commentary: RedPrairie, Wyle break; MGM, Lyondell CAM rise; Lyondell tweaks deal; Affinion sets talk
|
3/18/2010 | HY | Market Commentary: Junk primary pauses after big session; secondary slows; funds add $597 million; Smithfield up
|
3/17/2010 | HY | New Issue: BioScrip sells $225 million 5.5-year senior notes at par to yield 101/4%
|
3/17/2010 | HY | Market Commentary: Upsized QVC, Ball deals price, ILFC, SLM, BioScrip too; Blockbuster sags on Chapter 11 talk
|
3/16/2010 | HY | Market Commentary: Upsized U.S. Steel prices, Digicel also; market awaits BioScrip; new Bombardiers keep rising
|
3/16/2010 | HY | BioScrip talks $225 million 5.5-year senior notes to yield 101/4%-101/2%
|
3/12/2010 | HY | Market Commentary: Upsized Sirius, Huntsman price, Amsted also, Sitel sets talk; SuperValu mixed on buyout buzz
|
3/9/2010 | HY | BioScrip starts roadshow for $225 million 5.5-year note offering
|
3/9/2010 | HY | Market Commentary: Boise prices over-subscribed deal, MGM prices also, both firm; await Suburban Propane offering
|
3/2/2010 | BK | Market Commentary: Solutia dips on refinancing; HCA continues to rise; Ford inches up; BioScrip sets OID
|
3/2/2010 | BK | BioScrip $150 million credit facility to be issued at a discount of 98
|
2/26/2010 | BKHY | S&P rates BioScrip loans BB-, notes B-
|
2/24/2010 | HY | Moody's rates BioScrip notes B3
|
2/19/2010 | BK | BioScrip $150 million credit facility talked at Libor plus 400 bps
|
1/25/2010 | BKHY | BioScrip to get $150 million loan, $225 million notes for CHS purchase
|
8/6/2009 | SS | Heartland Advisors reduces ownership interest in BioScrip to 20.9%
|
3/24/2009 | SS | Heartland ups ownership in BioScrip to 21%
|
3/4/2009 | SS | BioScrip amends rights agreement
|